Overall, the PD-1 pathway has a crucial role in maintaining peripheral tolerance in normal conditions to prevent autoimmune diseases; however, in the TME, this pathway leads to the escape of tumor cells from immune response via the inhibition of CTL activation [64,71]. The gene discussed is PDCD1; the disease is neoplasm.